Category:Adult
Status:Active
This pilot phase II trial studies how well sapanisertib works in treating patients with bladder cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced) or ot...
Diagnosis: Bladder Cancer
Phase:
Protocol Number: 17-721
This is a study that will test how an experimental drug (enfortumab vedotin) affects patients with cancer of the urinary system (urothelial cancer). This type of cancer includes cancer of the bladd...
Diagnosis: Bladder Cancer
Phase:
Protocol Number: 17-376
In this study, participants with high risk non-muscle-invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette Guerin (BCG) therapy and who are considered ineligible for or have refused to...
Diagnosis: Bladder Cancer
Phase:
Protocol Number: 17-133
Avelumab and Radiation in Muscle-Invasive Bladder Cancer
This research study is studying the effects of adding a certain type of immunotherapy to standard bladder-directed radiation as a treatment for muscle-invasive urothelial carcinoma of the bladder. ...
Diagnosis: Bladder Cancer
Phase:
Protocol Number: 18-464
This research study is studying a new anti-cancer drug durvalumab (MEDI4736) with or without another new anti-cancer drug Oleclumab (MEDI9447) before surgery for bladder cancer. The drugs involved ...
Diagnosis: Bladder Cancer
Phase:
Protocol Number: 18-507